| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |